Opthea (ASX:OPT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Opthea (ASX:OPT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Change of Company Name, ASX Code and Registered Office
Results of EGM
Change of Director's Interest Notice - JL
Notification regarding unquoted securities - OPT
Becoming a substantial holder
Ceasing to be a substantial holder
Change of Director's Interest Notice - KC & LG
Ceasing to be a substantial holder
Ceasing to be a substantial holder
Change in substantial holding
Change in substantial holding
Revised Webinar Details and Investor Presentation
Becoming a substantial holder
Change in substantial holding
Change in substantial holding
Notice of Market Update
Change in substantial holding
Reinstatement to Official Quotation
Opthea Limited reinstated to quotation after strategic review announcement
Reinstatement to ASX and Update on LAM Development Program
Opthea reinstated to ASX, advances OPT-302 development for rare lung disease LAM
Notice of Extraordinary General Meeting/Proxy Form
Securities Trading Policy
Quarterly Activities/Appendix 4C Cash Flow Report
Opthea initiates LAM program, maintains AUD 31.2M cash, seeks ASX reinstatement